{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T09:07:23Z","timestamp":1666775243842},"reference-count":19,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/ol.2016.4357","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T05:44:43Z","timestamp":1458539083000},"page":"3205-3209","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report"],"prefix":"10.3892","volume":"11","author":[{"given":"KOTA","family":"SHIGETO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUMI","family":"KAWAGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"NIIZEKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASUSHI","family":"KUNITAKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDETOSHI","family":"TAKEDATSU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSUYUKI","family":"TONAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIMINORI","family":"FUJIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASATOSHI","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOSHI","family":"ABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HISANORI","family":"NAITO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUJI","family":"TORIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"key20180108094655_b1-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: Pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","author":"Salerno","year":"2010","journal-title":"Liver Int"},{"key":"key20180108094655_b2-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"key20180108094655_b3-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/hep.23522","article-title":"Tolvaptan and hyponatremia in a patient with cirrhosis","volume":"51","author":"Boyer","year":"2010","journal-title":"Hepatology"},{"key":"key20180108094655_b4-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/hepr.12099","article-title":"ASCITES Dose-Finding Trial Group: Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial","volume":"44","author":"Okita","year":"2014","journal-title":"Hepatol Res"},{"key":"key20180108094655_b5-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"SALT Investigators: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108094655_b6-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00535-010-0240-6","article-title":"A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety and dose-response of tolvaptan in patients with decompensated liver cirrhosis","volume":"45","author":"Okita","year":"2010","journal-title":"J Gastroenterol"},{"key":"key20180108094655_b7-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/hepr.12098","article-title":"ASCITES-DOUBLEBLIND Study Group: Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial","volume":"44","author":"Sakaida","year":"2014","journal-title":"Hepatol Res"},{"key":"key20180108094655_b8-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/apt.12025","article-title":"Meta-analysis: The safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia","volume":"36","author":"Dahl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108094655_b9-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/00000658-197410000-00023","article-title":"Peritoneo-venous shunting for ascites","volume":"180","author":"Leveen","year":"1974","journal-title":"Ann Surg"},{"key":"key20180108094655_b10-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0032-1312574","article-title":"Percutaneous placement and management of peritoneovenous shunts","volume":"29","author":"Martin","year":"2012","journal-title":"Semin Intervent Radiol"},{"key":"key20180108094655_b11-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites","volume":"325","author":"Gin\u00e8s","year":"1991","journal-title":"N Engl J Med"},{"key":"key20180108094655_b12-ol-0-0-4357","first-page":"1607","article-title":"Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt","volume":"60","author":"Nitta","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"key20180108094655_b13-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1478-3231.2008.01912.x","article-title":"Long-term increase in liver volume after Denver peritoneovenous shunt: Report of two cases","volume":"29","author":"Miyaaki","year":"2009","journal-title":"Liver Int"},{"key":"key20180108094655_b14-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1038\/ctg.2013.20","article-title":"Development and validation of a symptom scale specific for ascites accompanied with cirrhosis: The ASI-7","volume":"5","author":"Onishi","year":"2014","journal-title":"Clin Transl Gastroenterol"},{"key":"key20180108094655_b15-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"key20180108094655_b16-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1319-3767.141687","article-title":"Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients","volume":"20","author":"Girleanu","year":"2014","journal-title":"Saudi J Gastroenterol"},{"key":"key20180108094655_b17-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cgh.2013.08.050","article-title":"Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis","volume":"12","author":"Kawaguchi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180108094655_b18-ol-0-0-4357","article-title":"Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)","author":"Nahon","year":"2015","journal-title":"Gut: gutjnl-2015-310275"},{"key":"key20180108094655_b19-ol-0-0-4357","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4357\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T06:23:53Z","timestamp":1515392633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,21]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/ol.2016.4357"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4357","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}